Piper Sandler initiated coverage on shares of Bright Health Group (NYSE:BHG) in a research report report published on Monday morning, PriceTargets.com reports. The brokerage issued an overweight rating and a $24.00 price objective on the stock. Piper Sandler also issued estimates for Bright Health Group’s Q2 2021 earnings at ($0.08) EPS, Q3 2021 earnings at ($0.13) EPS, Q4 2021 earnings at ($0.30) EPS, FY2021 earnings at ($0.56) EPS, Q1 2022 earnings at $0.00 EPS, Q2 2022 earnings at ($0.06) EPS, Q3 2022 earnings at ($0.15) EPS, Q4 2022 earnings at ($0.29) EPS, FY2022 earnings at ($0.50) EPS, FY2023 earnings at ($0.38) EPS, FY2024 earnings at ($0.18) EPS and FY2025 earnings at $0.10 EPS.
BHG stock opened at $12.38 on Monday. Bright Health Group has a 52 week low of $11.64 and a 52 week high of $17.93.
In related news, major shareholder Scott D. Sandell bought 1,944,444 shares of the business’s stock in a transaction dated Monday, June 28th. The stock was acquired at an average price of $18.00 per share, with a total value of $34,999,992.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Bright Health Group, Inc, an integrated care delivery company, engages in the delivery and financing of health insurance plans in the United States. It operates in two segments, NeueHealth and Bright HealthCare. The company offers individual and family, Medicare, and employers insurance plans. It also operates 28 managed and affiliated risk-bearing primary care clinics.
Recommended Story: Bond
Receive News & Ratings for Bright Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bright Health Group and related companies with MarketBeat.com's FREE daily email newsletter.